(Press-News.org) Las Vegas, NV—CONRAD, a leading reproductive health research organization, will announce results of the SILCS Diaphragm contraceptive effectiveness study September 17th at the Reproductive Health 2011 Conference in Las Vegas, Nevada. The two-year study of 450 U.S. women implemented at six clinical sites in the U.S. showed that effectiveness rates of the new single size, contoured diaphragm are similar to traditional diaphragms. In addition, SILCS was shown to be easy to use and comfortable to wear. The single-size design eliminates the need for a fitting, which should reduce the amount of time required to provide this method, and opens the potential for providing the method outside of a clinic setting in the future, if allowed by regulatory authorities.
Jill Schwartz, M.D., CONRAD's medical director and study principal investigator said, "Women and societies worldwide suffer from the consequences of unintended pregnancies. By expanding their contraceptive options with easy-to-use methods that have minimal side effects, we're also expanding the potential for women's overall health, not to mention, their families welfare." She added, "Study participants reported high marks for ease of use and comfort for both women and their partners, which is so important—the only methods that work are the kind that women will actually use."
The SILCS Diaphragm was developed at PATH, an international nonprofit organization whose mission is to improve the health of people around the world, and validated in collaboration with researchers at CONRAD. Development of the SILCS Diaphragm involved a user-centered design process incorporating input from women, their partners, and providers. This feedback led to an innovative design that is comfortable and easy to use—even for women with no previous diaphragm experience. The SILCS device was developed to improve reproductive health in low-resource settings, where women have a limited range of contraceptive methods and where diaphragms are not currently available. This new diaphragm may also be important for women in developed countries, particularly for women who cannot or do not want to use hormonal methods or an IUD.
PATH's Vice President and Senior Advisor for Technologies, Dr. Michael Free said, "High rates of unintended pregnancy and discontinuation of current contraceptive methods suggest that existing contraceptive methods do not adequately meet the reproductive health needs of all women. This newly designed, discreet, and reusable cervical barrier could expand women's options for nonhormonal protection, thereby improving women's reproductive health especially in low resource settings."
Michael Thomas, M.D., ARHP Board Chair added, "The Association of Reproductive Health Professionals (ARHP) is honored that CONRAD and PATH have decided to release this pivotal new data at our Reproductive Health 2011 Conference. ARHP is committed to advancing multipurpose prevention technologies and is very excited by the promising developments coming out of the SILCS study."
Funding support was provided by the U.S. Agency for International Development (USAID) and the Bill & Melinda Gates Foundation. Kessel Marketing & Vertriebs GmbH of Frankfurt, Germany, will be manufacturing the SILCS Diaphragm under license from PATH. Kessel and CONRAD are preparing regulatory applications for Europe and the United States. Regulatory approval as a nonprescription device will be determined on a country-by-country basis according to the local norms and guidelines. Through a phased approach, the product will be introduced at an affordable price in both developed and developing countries.
The development of the new device was a response to women calling for a broader choice of contraceptive methods that are under their control, can be easily stopped and started, and nonhormonal, thus eliminating side effects. The diaphragm is also more discreet than a male or female condom and less disruptive of spontaneity. Studies will continue to research its potential as a dual protection method by serving as a delivery device for a microbicide gel that can prevent HIV infection.
CONRAD has been developing new methods of contraception for men and women for 25 years. This includes both hormonal methods as well as barrier devices such as the female condom and cervical caps. CONRAD is spearheading regulatory work toward registration of tenofovir gel, the first vaginal microbicide proven to reduce HIV and herpes infection.
###
Reproductive Health is the premier conference in reproductive and sexual health sponsored annually by the Association of Reproductive Health Professionals.
CONRAD was established in 1986 and is a Division of the Department of Obstetrics and Gynecology at Eastern Virginia Medical School (EVMS) in Norfolk, VA, where it has laboratories and a clinical research center. The main office is located in Arlington, VA, with additional offices in West Chester, PA, and collaborators around the world. CONRAD is committed to improving reproductive health by researching and developing new contraceptive options and products to prevent HIV and STI infections. For more information, please go to: www.conrad.org.
PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH's work improves global health and well-being. For more information, please visit www.path.org.
CONRAD presents results of pivotal contraceptive study at Reproductive Health 2011
Single-size diaphragm expands women's protection options
2011-09-19
ELSE PRESS RELEASES FROM THIS DATE:
T cells making brain chemicals may lead to better treatments for inflammation, autoimmune diseases
2011-09-19
MANHASSET, NY -- Scientists have identified a surprising new role for a new type of T cell in the immune system: some of them can be activated by nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The discovery of these T cells is novel and suggests that it may be possible to treat inflammation and autoimmune diseases by targeting the nerves and the T cells. The study was published this week in Science.
"The discovery that 2 percent of T cells can make acetylcholine under the control of nerves gives a new insight into how the nervous system regulates ...
Bold Earth Teen Adventures Adds Diversity With Teens From Over 50 Countries for Summer 2011
2011-09-19
Bold Earth Teen Adventures is seeing an increase in international interest for student travel as teens from outside the USA grew to represent 25% of their summer 2011 trips. International students are enrolling at a high rate, and this summer marks the first time that Bold Earth welcomed students from new countries including China, Japan, Korea, Iceland and Nigeria.
"Summer 2011 opened up Bold Earth to a new level of diversity that we're so proud of," said Abbott Wallis, President of Bold Earth. "Teens from all over the world are craving these rich experiences. ...
A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find
2011-09-19
Yang Wang is known for conducting complex research using highly sophisticated equipment. Yet the Florida State University geochemist also has spent days hiking through the remote outback of Tibet and camping in the foothills of the Himalayas — all in the name of scientific discovery.
Because of that unique mix of skills, Wang was chosen to take part in a team of researchers that uncovered the oldest prehistoric woolly rhino ever found. A paper describing the team's discovery was just published in Science (http://www.sciencemag.org/), a prestigious journal established ...
Pitt team finds molecular evidence of brain changes in depressed females
2011-09-19
PITTSBURGH, Sept. 16 – Researchers at the University of Pittsburgh School of Medicine have discovered molecular-level changes in the brains of women with major depressive disorder that link two hypotheses of the biological mechanisms that lead to the illness. Their results, published online this week in Molecular Psychiatry, also allowed them to recreate the changes in a mouse model that could enhance future research on depression.
Although women are twice as likely as men to develop depression and have more severe and frequent symptoms, very little research has focused ...
Sound Design by PopMark Media's Studio Unknown for "Lovely Molly" Receives Praise
2011-09-19
The sound design of the feature film, "Lovely Molly" (Amber Entertainment, Haxan Films), which debuted at the Toronto Film Festival on Wednesday, September 14th, is receiving high praise from industry bloggers. PopMark Media's Sound Division, Studio Unknown, was responsible for the full sound design package of the film.
Directed by Eduardo Sanchez, known for his 1999 horror, "The Blair Witch Project," "Lovely Molly" centers on a troubled young woman and the evil power that exists inside her. The film relies heavily on sound for story support. ...
Unknown ocean bacteria create entirely new theories
2011-09-19
The earth's most successful bacteria are found in the oceans and belong to the group SAR11. In a new study, researchers from Uppsala University provide an explanation for their success and at the same time call into question generally accepted theories about these bacteria. In their analysis they have also identified a rare and hitherto unknown relative of mitochondria, the power stations inside cells.The findings were published in two articles in the journals Molecular Biology and Evolution and PLoS One in the last week.
"The huge amounts of DNA information now being ...
Genetics may explain why calcium increases risk for prostate cancer
2011-09-19
WINSTON-SALEM, N.C. – Sept. 16, 2011 – A study by epidemiologists at Wake Forest Baptist Medical Center and colleagues suggests that a high intake of calcium causes prostate cancer among African-American men who are genetically good absorbers of the mineral.
"High dietary intake of calcium has long been linked to prostate cancer but the explanation for this observation has been elusive," said Gary G. Schwartz, Ph.D., associate professor of cancer biology, urology, and public health sciences at Wake Forest Baptist and co-author on the study.
Schwartz and colleagues ...
Virus a potential future cancer medicine
2011-09-19
In a new project, researchers from LIFE – the Faculty of Life Sciences at the University of Copenhagen – document that the vesicular stomatitis virus (VSV) plays a previously unknown dual role in the prevention of a number of cancers. The new findings show that the virus both kills cancer cells and stops the expression of the molecules which certain types of cancer cells produce to hide from the immune system.
Certain types of cancer cells express far too many liquid immunostimulatory molecules, blocking the immune system's ability to recognise them, and enabling them ...
MRI research demonstrates ALS attacks multiple parts of the brain
2011-09-19
Recently published studies by a researcher in the Faculty of Medicine & Dentistry demonstrate that ALS – known as Lou Gehrig's disease – damages neurons in parts of the brain responsible for cognition and behaviour.
ALS, which stands for amyotrophic lateral sclerosis, is a fatal neurodegenerative disease that eventually leaves patients unable to move, breathe or swallow. Previous research has shown about 50 per cent of patients with ALS also have mild cognitive and behavioural changes, but between five and 15 per cent of patients can have severe changes resulting in dementia. ...
Researchers identify potential molecular target to prevent growth of cancer cells
2011-09-19
GALVESTON, September 16, 2011 – Researchers have shown for the first time that the protein fortilin promotes growth of cancer cells by binding to and rendering inert protein p53, a known tumor suppressor. This finding by researchers at the University of Texas Medical Branch may lead to treatments for a range of cancers and atherosclerosis, which p53 also helps prevent, and appears in the current print issue of the Journal of Biological Chemistry.
"The p53 protein is a critical defense against cancer because it activates genes that induce apoptosis, or the death of cells. ...
LAST 30 PRESS RELEASES:
Volcanic eruption caused Neolithic people to sacrifice unique "sun stones"
Drug in clinical trials for breast cancer could also treat some blood cancers
Study identifies mechanism underlying increased osteoarthritis risk in postmenopausal females
The material revolution: How USA’s commodity appetite evolved from 1900 to present
Asteroid impact sulfur release less lethal in dinosaur extinction
Study shows seed impact mills clobber waterhemp seed viability
Study links rising suicidality among teen girls to increase in identifying as LGBQ
Mind’s eye: Pineal gland photoreceptor’s 2 genes help fish detect color
Nipah virus: epidemiology, pathogenesis, treatment, and prevention
FDA ban on Red Dye 3 and more are highlighted in Sylvester Cancer's January tip sheet
Mapping gene regulation
Exposure to air pollution before pregnancy linked to higher child body mass index, study finds
Neural partially linear additive model
Dung data: manure can help to improve global maps of herbivore distribution
Concerns over maternity provision for pregnant women in UK prisons
UK needs a national strategy to tackle harms of alcohol, argue experts
Aerobic exercise: a powerful ally in the fight against Alzheimer’s
Cambridge leads first phase of governmental project to understand impact of smartphones and social media on young people
AASM Foundation partners with Howard University Medical Alumni Association to provide scholarships
Protective actions need regulatory support to fully defend homeowners and coastal communities, study finds
On-chip light control of semiconductor optoelectronic devices using integrated metasurfaces
America’s political house can become less divided
A common antihistamine shows promise in treating liver complications of a rare disease complication
Trastuzumab emtansine improves long-term survival in HER2 breast cancer
Is eating more red meat bad for your brain?
How does Tourette syndrome differ by sex?
Red meat consumption increases risk of dementia and cognitive decline
Study reveals how sex and racial disparities in weight loss surgery have changed over 20 years
Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests
In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior
[Press-News.org] CONRAD presents results of pivotal contraceptive study at Reproductive Health 2011Single-size diaphragm expands women's protection options